Sign up to save your podcasts
Or
Share Steve McGloughlin: "Septic Shock – Beyond antibiotics, fluids and inotropes – is there benefit from ECMO or novel therapies?"
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Steve McGloughlin: "Septic Shock – Beyond antibiotics, fluids and inotropes – is there benefit from ECMO or novel therapies?"
Despite the advances of modern critical care, there is remarkably little that has been demonstrated to change the trajectory of septic shock. We still rely on early recognition, good supportive care and appropriate antimicrobials to help these patients. This talk will focus on why these therapies are still the mainstays and how we need to work hard to ensure that in the near future – novel therapies and complex supportive care mechanisms such as ECMO can help the sickest patients.
View all episodes
By Australian Sepsis NetworkDespite the advances of modern critical care, there is remarkably little that has been demonstrated to change the trajectory of septic shock. We still rely on early recognition, good supportive care and appropriate antimicrobials to help these patients. This talk will focus on why these therapies are still the mainstays and how we need to work hard to ensure that in the near future – novel therapies and complex supportive care mechanisms such as ECMO can help the sickest patients.